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1. ABSTRACT
Cancer is a complex and multigenic disease, which is typically
initiated by genetic mutations in tumor suppressor genes that
regulate homeostatic mechanisms within cells. Oncogenic
promoter mutations, like those involved in signal transduction
pathways, also have the potential to induce cancer in an otherwise
healthy organism. Transformation is highly dependent upon
mutations to both tumor suppressor and oncogenes, as neither
mutation is exclusive in its ability to generate malignant tumors. In
the model organism, Drosophila melanogaster, I have generated
metastatic cancer through the genetic effect of overactive Raf
signaling, in conjugation with silencing selected tumor suppressor
genes using RNA interference. Metastasis, the uncontrollable
migration of cancer to non-adjacent areas within an organism, was
analyzed in vivo, using Green Fluorescent Protein as an indicator
for the presence of mutant tissue. Scribble (scrib) and Discs large
(Dlg), two genes involved in cell polarity, demonstrated the
highest incidence of metastatic cancer when silenced using RNAi.
This novel preliminary screen exhibits the influential role of Raf
signaling and cell polarity genes in generating metastatic cancer.
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2. INTRODUCTION
Cancer
As the second leading cause of death in the United States,
cancer has become a national as well as global pandemic (Cancer
Facts & Figures, 2012). With more than 1,000,000 new national
diagnoses and 500,000 plus cancer-related deaths expected to
occur in 2012, this disease is aggressive and deadly at its worst
(Cancer Facts & Figures, 2012). As such, more pressure is being
placed upon researchers to discover the mechanisms that enable
cancer to completely alter cellular behavior.
A scientific breakthrough occurred when one researcher,
Alfred Knudson, discovered a model to explain the development of
cancer, which eventually became known as the “Two-Hit Theory
of Cancer Causation” (Knudson’s ‘Two-Hit’ Theory of Cancer
Causation). In this model Knudson states that in order for normal
cells to transform into cancerous ones, two mutations must occur
(Knudson’s ‘Two-Hit’ Theory of Cancer Causation). He argues
that the first mutation is genetic, as one inherited chromosome
becomes damaged at conception, birth, or a later stage in life
(Knudson’s ‘Two-Hit’ Theory of Cancer Causation). When
another mutation occurs to that same gene, a “second hit” occurs
(Knudson’s ‘Two-Hit’ Theory of Cancer Causation). This hit, in
concert with the first mutation, enables the transformation of
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cancerous cells (Knudson’s ‘Two-Hit’ Theory of Cancer
Causation).
Mutations are able to occur through a variety of mechanisms, like
subtle sequence changes, alterations in chromosome number,
chromosome translocations, and gene amplifications (Lengauer,
Kinzler, and Vogelstein, 1998). In many tumors there has also
been a major loss or gain of chromosomes, resulting in different
cancerous conditions (Lengauer, Kinzler, and Vogelstein, 1998).
For instance in glioblastomas, there is a loss in chromosome 10,
which inactivates Pten, a tumor suppressor gene (Lengauer,
Kinzler, and Vogelstein, 1998).
As such, the stability of tumors is indirectly related to the
mutation prevalence among cells (Lengauer, Kinzler, and
Vogelstein, 1998). Such instability can result from cellular
environmental conditions, like in cell-cell interactions (Lengauer,
Kinzler, and Vogelstein, 1998). As tumors develop from continual
and uncontrollable cellular proliferation, they are able to be
classified as benign or malignant (Understanding Cancer Series).
This classification is dependent upon the invasiveness of tumors,
or their ability to metastasize (Understanding Cancer Series).
Localized tumors are unable to spread to new sites and, as such,
are not considered invasive (Understanding Cancer Series).
However, cancerous tumors are able to invade neighboring tissues
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through metastasis, and even induce blood vessel growth nearby
and within the tumor through angiogenesis (Understanding Cancer
Series). As such, only malignant tumors are considered to be
cancerous (Understanding Cancer Series).
An in-depth study of malignant tumors has shown cancer to
possess six fundamental traits: a “self-sufficiency in growth
signals, insensitivity to growth-inhibitory (antigrowth) signals,
evasion of programmed cell death (apoptosis), limitless replicative
potential, sustained angiogenesis, and tissue invasion and
metastasis” (Hanahan and Weinberg, 2000). My project
specifically focuses on two of these fundamental traits – a selfsufficiency in growth signals as well as tissue invasion and
metastasis.
Signaling Pathways
Multiple regulatory systems in living organisms are
controlled by signaling pathways, which influence cellular growth.
These pathways consist of numerous proteins that are triggered by
a signal, causing an appropriate response within the cell. Upon
ligand reception, a chain reaction occurs so that each protein
becomes activated by the previous protein, carrying the signal to
the nucleus of the cell. It is in the nucleus that gene expression is
affected, causing for the cell to become changed.
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Mitogenic growth signals are required for normal cells to
change from a dormant state into one that is active and
proliferative (Hanahan and Weinberg, 2000). As such, signaling
molecules are necessary in order for cell growth to occur. Some
oncogenes predispose cells to cancer by mimicking such signals,
thereby altering cellular signaling pathways (Hanahan and
Weinberg, 2000). GTPase signaling pathways are particularly
interesting, as uncontrolled signaling leads to an increase in
cellular proliferation and malignant transformation (Reuter,
Morgan, and Bergmann, 2000).
As such, these tumor cells exhibit a reduced dependency
upon growth signaling in comparison to normal, healthy cells
(Hanahan and Weinberg, 2000). Therefore, a signal is no longer
required as the cell becomes completely independent of necessary
growth signals. This renders inactive such an important
homeostatic mechanism in controlling normal cell-like behavior
(Hanahan and Weinberg, 2000). In order to induce self-sufficient
proliferation, cancerous cells synthesize growth-signaling factors
causing a positive feedback-signaling loop within the cell
(Hanahan and Weinberg, 2000). Cancerous cells also manipulate
growth factor receptors, as these cell membrane receptors receive
such growth signals, thereby affecting gene regulation within the
cell. However, tumor cells cause overactivity in the tyrosine kinase
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activity of growth factor receptors, as well as ligand independent
signaling, causing a hypersensitivity to signaling in cancerous cells
(Hanahan and Weinberg, 2000).
When mutations like this lead to an overactive signaling
pathway, proteins are continually active without any regulatory
mechanism. As one of the defining traits of cancer,
overproliferation allows cells to become limitless in their
replicative potential. As such, mutated proteins involved in
overactive signaling pathways are considered oncogenes, because
these genes contribute to the initiation or progression of cancer
(Hanahan and Weinberg, 2000). In fact, within stomach, brain, and
breast tumors, the epidermal growth factor receptor has been
proven to be upregulated, affecting the pathogenicity of these cells
(Hanahan and Weinberg, 2000).
Epidermal growth factor receptors, or EGFR’s, are
responsible for initiating two important signaling pathways: the
RAS-RAF-MAP kinase and the PDK1-AKT pathways (Benvenuti,
et. al, 2012). Cancerous cells also possess different extracellular
matrix receptors, or integrins, which promote pro-growth signals
(Hanahan and Weinberg, 2000). Such integrins enable the
overactivation of the RAS-RAF-MAPK pathway (Hanahan and
Weinberg, 2000).
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Although it is known that these signaling pathways, when
overactive, promote overproliferation, these biological changes are
not sufficient to actually cause cancer – only a predisposition to it.
However, mutations that induce overproliferation can sometimes,
in concert with other mutations, lead to metastasis.
Metastasis
Metastasis occurs when tumourous cells migrate from one
organ to another, non-adjacent organ (Understanding Cancer
Series). The migration of cancer cells is able to occur through
uncontrolled mitosis or by the blood stream and lymphatic system
(Understanding Cancer Series). When cancerous cells move to a
new location in the body due to metastasis, a secondary tumor, or
metastatic site forms (Understanding Cancer Series). As previously
noted, benign and malignant cancers differ in their ability to
metastasize; metastasis is a hallmark of malignant cancer
(Understanding Cancer Series).
Neoplastic growth occurs as cells continue to grow in an
uncontrollable manner, causing cells to begin to pile on top of one
another (Basler, Toggwiler, Willecke, 2011). With constrained
space for growth, cells begin to migrate into new areas and tissues,
becoming cancerous (Basler, Toggwiler, Willecke, 2011). Unlike
neoplastic growth, hyperplasia results only in the proliferation of
non-metastatic cells (Halder and Mills, 2011). Accordingly,
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mutations in neoplastic tumor suppressor genes contribute to the
invasiveness of tumors (Halder and Mills, 2011).
The ability of cancer to spread to ectopic locations occurs
through mutations related to the regulation of cellular processes –
particularly those involved in migration and cell-cell adhesion
(Hanahan and Weinberg, 2000). Since multiple regulatory systems
in living organisms are controlled by signaling pathways, it is no
surprise that mutated signaling pathways have been known to
contribute to cancer. However, both negative and positive
regulatory processes are necessary in order to generate metastasis
(Liotta, Steeg, and Stetler-Stevenson, 1991).
Unrestrained growth is unable to individually initiate
metastasis, as misregulation of motility and proteolysis is also
required to induce tumor invasion (Liotta, Steeg, and StetlerStevenson, 1991). Once invasion has occurred, cancerous cells
must be able to “arrest at the distant vascular bed, extravasate into
the target organ interstitium and parenchyma, and proliferate as a
secondary colony” (Liotta, Steeg, and Stetler-Stevenson, 1991).
Tumors exist as a subpopulation of cells with special
characteristics; cells become metastatic as they migrate from the
original tumor (Liotta, Steeg, and Stetler-Stevenson, 1991).
Interestingly enough, it has been shown through the use of genetic
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markers that this subpopulation dominates the growth of the
primary tumor (Liotta, Steeg, and Stetler-Stevenson, 1991).
However, in order for such subpopulations to form, cancerous cells
must first pass through the basement membrane, a dense matrix
that prevents cellular traversal (Liotta, Steeg, and StetlerStevenson, 1991). Only through invasion of the basement
membrane is metastases able to occur as cancerous cells enter the
blood stream and lymphatics (Liotta, Steeg, and Stetler-Stevenson,
1991). As such basement membrane degradation is a common
feature among many carcinomas; this structure remains intact in
benign tumors (Liotta, Steeg, and Stetler-Stevenson, 1991). As
such, proteolysis, or the degradation of cellular proteins, is also a
feature of metastasis (Liotta, Steeg, and Stetler-Stevenson, 1991).
When proteolysis is coupled with motility, invasion is able to
occur in cancerous cells allowing for the formation of metastatic
sites (Liotta, Steeg, and Stetler-Stevenson, 1991).
Drosophila melanogaster
In determining the occurrence of metastasis, Drosophila
melanogaster was used as my model organism. The use of this
organism as a scientific model is very advantageous, due to the
fly’s small size and genome, with highly conserved sequences
shared between the fly and human population.
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With a genome consisting of 165 million base pairs, 4
chromosomes, and about 14,000 genes, Drosophila genes have
easily recognized human homologues (Twyman, 2002). As such,
research performed using Drosophila is able to contribute to a
general understanding of human diseases and disorders.
Additionally, as a small organism, large numbers of
Drosophila are easily maintained within vials and bottles. This
allows for multiple experiments to occur in a research lab
regardless of limited space. Drosophila also has a short life cycle,
which allows for relatively quick results when inducing mutations
within the fly. One generation of Drosophila takes approximately
seven to eight days to reach maturity, transforming from an egg, to
larvae, then pupae, and eventually a fly (See Figure 2.1). Within
any given cross, pending it is at 25°C, progeny appears
approximately ten days after crossing. By crossing flies of different
genotypes, mutations are easily induced.
As my project utilizes signaling pathways in order to cause
malignancy, Drosophila was an extremely beneficial organism to
use; many known components within signal transduction pathways
were originally discovered using the fruit fly (Halder and Mills,
2011). Through Drosophila, the flippase system was able to be
utilized in order to create homozygous mutant cells, as similarly
performed in
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other Drosophila genetic screens (Halder and Mills, 2011).
Multiple transgenic stocks have also been created carrying
different genomes of silenced tumor suppressor genes, which were
necessary for my experiment (Halder and Mills, 2011).
In order to successfully model cancer, it is vital that
specific, complex genotypes be created in groups of cells, and that
their behavior properly followed (Halder and Mills, 2011).
Drosophila not only allows for the creation of such genetically
modified clones but also enables successful tracking through the
use of the Flippase/FRT system (Halder and Mills, 2011).
Project Overview
In my Capstone Project I attempted to generate metastasis
within Drosophila melanogaster by first combining Raf-activated
and RNAi transgenes and then crossing them to an eye/antennal
epithelium specific Gal4 driver line. This required me to generate a
stable stock with an overactive RAS-RAF-MAPK signaling
pathway by targeting the Raf protein. In the Raf gain of function
mutation, the signaling pathway was manipulated so that the Raf
protein was continually phosphorylated, causing for the pathway to
become hyperactive. In order to create a stock of flies carrying this
genotypic mutation, as well as balancers, multiple crosses were
performed.
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Since tumorigenesis is multigenic by nature, metastasis
could only potentially be induced by also silencing a tumor
suppressor gene. A small preliminary screen was performed, in
which a total of fifteen tumor suppressor genes were knocked
down using an RNA interference mechanism. Flies carrying the
genotype containing the silenced genes were mated to those with
the hyperactive signaling pathway in order to induce cancer within
the progeny.
Theoretically, since the offspring of this cross were
carrying both mutations, the formation of malignant, metastatic
tumors was more likely in these flies than if their genome had
consisted of only one mutation. As such, analysis of the offspring
carrying the double mutation was compared to other progeny of the
cross that carried only the RNAi or the oncogene.
When studying the RafACT flies, it was expected that there
would be an overgrowth, but no migration, of GFP positive cells.
However, when analyzing the RafACT + gene X- (where gene ‘X’ is
knocked out) flies, GFP positive cells will be detected at ectopic
locations, whenever the RafACT and the knocked out gene caused
metastasis together. This stage in my project was important in
determining if various interactions between overactive signaling
pathways and specific genetic knockouts cause for cancerous cells
to metastasize.
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All larvae were analyzed in vivo using Green Fluorescent
Protein as a marker, in order to determine the occurrence of
metastasis. The FLP/FRT and UAS/Gal4 systems ensured that the
green marker was localized within the developing eye epithelium
of the fly, when visualized using the fluorescent microscope. As
such, GFP was seen in ectopic locations, areas other than the eye
discs, when malignant tumors formed.
In conclusion, my Capstone Project allowed me to identify
second site mutations that lead to metastasis. It also enabled me to
perform research on a signaling pathway protein that had not
previously received significant scientific attention in comparison to
the protein Ras. Utilizing both mutations, I demonstrated the
significance of this protein in causing malignancy, as well as the
necessity of cell polarity genes in preventing the formation of
malignant tumors.
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3. METHODOLOGY
Flipping
Flies are maintained within plastic vials or plastic bottles
dependent on the amount of flies in a particular cross or stock.
Approximately 20 flies are maintained within vials, while a bottle
can sustain more than double this amount. To ensure proper
nutrient supply, flies are flipped regularly to new vials and bottles
that contain a layer of fresh food- consisting of mainly water,
dextrose, yeast, agar, and cornmeal. If less than 10 flies are
transferred, certain precautions must be taken to verify the health
of the stock. For instance, within any container there must be at
least a 3:1 ratio of females to males, with greater than half of these
flies appearing to be healthy. Three shakes of dry yeast should also
be added to any new vial before transferring. The label from the
old vial must also be transferred, with the new vial being dated as
well. Rather than disposing of the old vial, it should be taped to the
new transfer and placed back in the tray.
Wet Yeast Paste
If flies are particularly unhealthy, wet yeast paste can be
added to a vial or bottle. Yeast paste is also reproductively
advantageous, as it makes the food more appealing to the females,
thereby increasing the likelihood of eggs being laid. Wet yeast
paste is made by taking a relative amount of dry yeast and adding
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it to a 15 ml tube. Slowly a very minute amount of water is added
to the tube, just enough for the yeast to soak up the moisture. A
spatula is then used to mix the ingredients. While continuing to
stir, water is gradually added again until the mixture becomes a
paste. Using the spatula, the desired amount of paste is placed into
the vial or bottle by gently placing the substance onto the food and
side of the container; the yeast paste is very lightly mixed with the
food and spread in a line, a quarter-length, up one wall of the vial
or bottle.
Stocks
Stocks are fly lines that are genetically stable through the
use of balancers. Balancers ensure the desired genotype by
“balancing” the stocks. The most effective balancers suppress
genetic exchange along the total length of the chromosome
(Greenspan, 2004). By suppressing crossing over of homologous
chromosomes, balancers minimize the likelihood of genetic
recombination. This is due to the fact that “only those adults
doubly heterozygous for the balancer and the lethal-bearing
homolog survive” (Greenspan, 2004). A fundamental trait of
balancers is the presence of recessive lethal alleles and dominant
visible markers, thus homozygous balancer combinations (See
Figure 3.1) (Greenspan, 2004). Within my project, I used two
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balancers on the third chromosome: TM6B and TM3. TM6B
carries dominant Humeral (Hu) and Tubby (Tb) along with
recessive ebony (e) (Greenspan, 2004). TM3 instead carries
recessive ebony (e) in addition to Stubble (Sb) (Greenspan, 2004).
Expansion
Stocks must be expanded when many copies of the same
stock are needed for a given experiment. First, flies are flipped to a
new vial or bottle, where they must remain until eggs are visible on
the surface of the food. This typically takes three days at room
temperature. At this point, the adult flies are able to be transferred
to another new vial or bottle. Transfers may properly continue,
pending the adult flies are given enough time to seed with each
transfer. Expansion should end when the necessary amount of flies
for the stock is achieved or when the flies are no longer able to
sufficiently lay eggs. This typically occurs five days after the first
room temperature transfer. Vials are also able to expand into bottle
stocks when there are at least 20 flies within a healthy vial.
Bottlenecking
Bottlenecking occurs, as a safety precaution, when only one
set of the adult flies remains. It is safe to copy a stock when there
is crawling larvae visible within the designated vial. At this point
the adult flies can be transferred to a new vial with dry yeast,
assuming that there are enough males and females. The new vial
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should be labeled and dated appropriately. The old vial should be
saved.
Scientific Microscopy
Stereomicroscope
The stereomicroscope is used for sex and phenotypic
separation, crossing procedures, virgin collection, and larval
analysis. Light intensity is adjusted using the setting on the
microscope base. Bulbs are also adjustable. The coarse knob is
used to magnify the image, while the fine knob allows for
focusing.
Fluorescence Microscope
Samples are analyzed for metastasis using the fluorescence
microscope. When using this microscope, the differential
interference contrast (DIC) light must be turned off. Next, the
BINO/PHOTO filter must be removed. At this point the shutter can
then be opened. The color filter should be adjusted appropriately,
at FITC/CY2 to allow for GFP visualization. The coarse and fine
knobs adjust the discernability of the image. Using the microscope,
camera images are able to be obtained.
Confocal Microscope
Pictures of tissues are taken using the confocal microscope.
The microscope, camera, and fluorescence box are turned on
accordingly. The computer must also be running simultaneously,
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so that the LAS AF program can be utilized. Once slides are
loaded and clipped, the fifth icon down on the left-most side must
be touched. The double arrow or single arrow are used to
respectively move the stage up or down. Next the GFP
fluorescence is turned on. The 10X objective is used to find the
sample. Once the image is focused and centered, the stage must be
brought down and a drop of immersion oil must be added to the
slide. Switching to the 40X objective, the sample is refocused.
Ensuring the strongest intensity of GFP, the confocal software is
used to create an image of the sample.
Crosses
Punnett Square
Before performing a cross, a punnett square is made to
ensure that the desired progeny will result from mating. As
demonstrated in Figure 3.1, two axes are drawn with the females
shown horizontally and males vertically. In each sector of one axis,
all possible alleles, which are genetically transferrable from the
parent to offspring, are listed. Therefore each box of the diagram
represents possible combinations of both male and female gametes.
Each of these combinations signifies the possible genotypes of the
offspring. As such, the construction of a punnett square is
necessary in order to verify that the desired offspring is produced;
it is also used to note the other possible genotypes that could result
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from the mating. This allows for specific phenotypes to be selected
for further crossing schemes or in the creation of stocks.
Clearing
Vials and bottles must be completely cleared before virgin
collection occurs. When clearing a vial or bottle, all adult and nonvirgin flies are removed. Clearing is typically synonymous with
transferring flies, as a new copy is made while the old is used for
collection. However if there are enough copies, then removal
occurs by turning the vial or bottle upside down onto a CO2 pad;
the CO2 gauge level should not exceed to 10-20 ppm. These flies
are disposed of in the fly morgue, a flask consisting of ethanol. If
flies are still present in the container, then the same procedure can
be repeated or a paintbrush can be used to push the remaining flies
into the food.
Virgin Collection
The accuracy of a cross is dependent upon proper female
virgin collection. On the first day of collection, the designated
bottles are cleared and dry yeast is added to the container. A
kimwipe is folded into half and gently pushed into the bottom of
the food to increase the surface area for crawling larvae. Once all
eclosed flies are emptied, the bottles are placed at room
temperature. Six to seven hours later, flies are able to be scored on
the basis of sex. Newly emerged virgin females are distinguishable
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from adults by the presence of the meconium, a dark spot on the
abdomen, formed by food eaten during the larval stage
(Greenspan, 2004). Females are saved into vials with dry yeast;
each vial is labeled with number of virgins, their genotype, and the
date. Collection bottles should be double checked to make sure that
no flies remain; these bottles are placed at 18°C overnight.
Temperature affects the sexual maturity of flies: at 18°C flies take
18 hours to mature, while at 25°C it only takes 8 hours. Therefore,
it is important to collect before maturity is reached between each
collecting period. As such, flies should be collected no later than
18 hours after they are placed in the 18°C incubator overnight.
Collection continues using the outlined procedure until all
necessary virgins are obtained for crossing.
Sex Scoring
Distinguishing between males and females is crucial for
crossing. Males have sex combs, a rounded abdomen, dark bristles
on their genitalia, and dark coloring at the dorsal end of their
abdomen. Females have a pointed abdomen with lighter
pigmentation. Differences are distinguishable in Figure 3.2.
Crossing
When crossing, the following supplies are necessary: an
uncapped tray of vials, yeast shaker, bag of cotton, and virgin
female flies of the appropriate genotype. Virgin females are
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anesthetized by CO2. Using a paintbrush, the necessary amount of
virgins is added to empty vials containing dry yeast. As virgins are
added to each individual vial, they are capped using cotton balls to
ensure that no unwanted flies are able to enter the vial. The amount
of vials and virgins necessary is dependent on the number of
crosses performed. Once finished adding all virgin females, the
cross must be completed by adding the appropriate male flies.
Once these flies are obtained, they are also anesthetized using the
CO2 apparatus. Although a maximum of 1 male per 7 females is
sufficient for a cross, normally 2-3 males are used per 5 or more
females. Crosses are completed once males and females have been
added to the same vial. All vials must be labeled with the date,
cross scheme, and number of males and females in each vial. Vials
should be placed at the appropriate temperature.
Maintenance of Crosses
Cross vials are not able to be maintained using the same
procedure as stock vials. Three days after a cross is performed,
adults should be transferred to a new vial. This should resume at
the end of days 4, 5, and 6, with adults being flipped to a new vial.
This allows for a single cross to expand approximately five times.
Special circumstances arise when there is a scarcity or abundance
of flies; transfers can happen as early as day 2 if there is a surplus
of flies or as late as day 5 if there are very few flies present. Vials
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should be cleared of adult flies when pupae begin to appear, this
typically occurs at day 6 or 7 for the original cross vial. In transfer
vials, the first pupae will appear approximately five days after the
transfer date.
Phenotypic Scoring
Phenotypic scoring is crucial when performing crosses or
selecting specific progeny from a desired cross. At the larval stage,
male and females are able to be distinguished by the presence of
the male testes. The testes are detectable by a small, translucent
circle near the posterior end of the male larvae. The TM6B marker
is also able to be distinguished at the larval stage by the appearance
of tubby larvae; these larvae are shorter and fatter than the wild
type. In adult flies TM6B causes the humeral phenotype, as shown
in Figure 3.3. Humeral flies have greater or less than 2 large
bristles on their shoulder, where as wild-type phenotype consists of
only 2 macrochaetes.
Larval Dissection
The following supplies are necessary for larval dissection:
disposable transfer pipettes, a pair of forceps, glass 9-well plate,
plastic 24-well plate, tissue baskets, vial of larvae, 1X PBS, and a
dissecting pad. First, the glass wells in the 9-well plate are filled
with 1X PBS using a disposable transfer pipette. Next, a drop of
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1X PBS is added on the dissecting pad; each larval dissection
requires a separate drop. Using a paintbrush, 10 larvae are removed
from the vial and placed in a 1X PBS well. One larvae is
transferred to the dissecting pad using the forceps. The dissecting
pad is then placed under the light microscope in order to perform
the dissection. When dissecting, both forceps should gently pinch
some of the larval coating, with the forceps then being pulled in
opposite directions; this removes the skin tissue of the larvae. This
procedure is repeated until all skin is removed from the larvae,
with the skin being disposed of in a designated 1X PBS droplet on
the dissecting pad. After the skin is removed, unnecessary tissue
must also be eliminated. Both forceps are used to remove all tissue
except the ventral nerve cord, brain, antennal discs, eye discs, wing
discs, and mouth hooks. Excess tissue is also discarded in a
separate droplet. Once the sample is finished, it is transferred to a
basket located in 1X PBS in the plastic 24 well-plate. The above
procedure is repeated for all larvae, placing all finished samples in
the same basket; larvae tissue with different genotypes should not
be mixed. Once all tissue samples are obtained and placed in the
basket, the basket is transferred to another well plate filled with
PLP fixative. Tissues should be fixed in PLP for 15-20 minutes.
After this time period has passed the tissue samples are able to be
mounted. Dissection supplies are handled accordingly: transfer
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pipettes are disposed of in the trash, the glass well plate and
dissecting pad are
washed with water followed by an ethanol wash, and 1X PBS is
placed back in the 4°C fridge. Forceps are also cleaned with
ethanol using a kimwipe, and the vial of larvae is placed back at
the appropriate temperature.
Imaginal Disc/Antibody Staining
When necessary, antibody staining occurs after larval
dissection. After dissection, the tissue is fixed in PLP for 30
minutes at room temperature. At this same temperature, these
samples are washed for 5 minutes in 1X PBS and then twice in 1X
PBT, also for 5 minutes each. The primary antibody is then able to
be added at the appropriate dilution (in NGS/PBT). After this step,
these samples must be placed on the shaker overnight, for at least
10 hours, at 4˚C. The following morning, the well plate and
baskets are moved to room temperature, where the tissue is washed
in PBT, 3 times for 10 minutes each. Samples are washed for
another 3 cycles at 10 minutes each, in NGS/PBT. The secondary
antibody is then added in a 1:200 dilution (in NGS/PBT). These
samples are shaken again for 2 hours, at room temperature. Wash
cycles are then repeated at room temperature: washed in PBT 3
times for 10 minutes each and in PBS at 10 minutes each. Samples
are then able to be mounted using mounting solution.
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Mounting
Tissue samples are mounted on slides following dissection.
In order to mount the following supplies are required: mounting
solution, slides, cover slips, 1X PBS, disposable transfer pipettes,
and forceps. Before mounting it is necessary that slides are labeled
with the name of the sample being mounted, amount of samples
mounted, date, and initials. After labeling, one drop of 1X PBS is
added towards the end of the slide using a disposable transfer
pipette. The designated tissue to be mounted is placed within this
drop. Under the light microscope, the tissue is cleaned using a pair
of forceps; cleaning separates the tissues just enough so that they
can be discerned easily when mounted. Once the tissue is prepared,
one drop of mounting solution is added to the center of the slide
using a new transfer pipette. The prepped tissue is transferred to
the mounting solution and arranged accordingly. This procedure is
repeated until all tissue samples are added to the slide, with each
slide typically containing five samples. Once all samples are in the
mounting solution, a kimwipe is used to remove the drop of 1X
PBS. A coverslip is then gently placed over the mounting solution.
After a few minutes of drying, the coverslip is sealed using nail
polish, by brushing along all four edges of the square.
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Solutions
1XPBS
In vitro and in vivo larval analysis is performed in 1X PBS.
To make 1 L of PBS, 10 ml of 10X PBS is mixed with 90 ml of
Millipore water.
1X PBT
This solution is made by adding 1500 µl of 10% Triton
(1ml of Triton + 9ml of Millipore water) and 50 ml PBS.
NGS/PBT
This solution is necessary for the antibody staining
procedure, mixing: 1 ml of 100% NGS and 600 µl 10% Triton.
Using 1X PBS, this solution is then brought to 20 ml.
Mounting Solution
Mounting solution is required in order to preserve tissue
samples on slides: 0.40 g of n-propyl gallate, 800 µl of 10X PBS, 2
ml of enzyme-grade glycerol, 1.2 ml of H20 are combined into a 15
ml tube. The tube is then vortex in order to ensure that the solution
is thoroughly mixed. Mounting solution is stored at 4°C.
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4. RESULTS AND DISCUSSION
Induced Mutations
RafACT
An overactive RAS-RAF-MAPK signaling pathway was
induced in order to induce the first mutation within Drosophila.
Within this signaling pathway a signal is received by EGFR, which
triggers the action of Ras, a small G-protein (Benvenuti, et. al,
2012). G-proteins, or GTP-hydrolases, are extremely important
within this pathway as they enable activation through intermittent
conformational changes upon binding to guanosine diphosphate,
GDP, and guanosine triphosphate, GTP (Reuter, Morgan, and
Bergmann, 2000). When GTP-bound, Ras becomes activated from
the protein’s dormant, GDP-bound state (Reuter, Morgan, and
Bergmann, 2000). Guanine nucleotide exchange factors, like SOS,
serve as regulatory proteins to control the cycling rate of Ras
activation through GTP and GDP (Reuter, Morgan, and Bergmann,
2000). SOS stimulates Ras by enabling the dissociation of GDP,
thereby allowing for GTP incorporation (Reuter, Morgan, and
Bergmann, 2000).
When GTP bound, Ras activates an effector protein kinase
Raf, which initiates the mitogen-activated-protein kinase cascade
through phosphorylation (See Figure 4.1) (Benvenuti, et. al, 2012).
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The intrinsic regulatory mechanism of this signaling pathway is
extremely crucial in healthy cells, since hyperactive RAS-RAFMAPK pathways have been proven to be present in 25% of human
tumors (Hanahan and Weinberg, 2000). The presence of Ras
oncogenes have also been confirmed in approximately half of
human colon carcinomas (Hanahan and Weinberg, 2000). In these
tumors, the Ras protein is mutated so that mitogenic growth signals
are continually released, causing habitual cellular stimulation
(Hanahan and Weinberg, 2000).
Within my project, I targeted the Raf protein in order to
cause overactivity of the RAS-RAF-MAPK pathway. As shown in
Figure 4.1, Ras triggers multiple pathways by potentially
phosphorylating RalGEF, PI3K, or Raf (Reuter, Morgan and
Bergmann, 2000). Hyperactivity in both the RAS-RAF-MAPK and
PI3K pathways have shown to be correlated with tumorigenesis,
however only RAF/MAPK pathway overactivity induces
metastasis (Janda, et al., 2002). This pathway is also known to be
required for initiating transforming growth factor ß epithelial
mesenchymal transition, or TGFß EMT (Janda, et al., 2002). EMT
is “characterized by spindle-like cell morphology, loss of epithelia
markers, and induction of mesenchymal markers” (Janda, et al.,
2002). Oncogenic Raf has also been shown to prevent TGFßinduced apoptosis as well as create more contact between cells and
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their migration (Janda, et al., 2002). As such, I decided to use a
mutation of Raf that led to hyperactivation of the RAS-RAFMAPK pathway in order generate malignant tumors within the fly.
RNAi Mechanism
RNA interference was used as a technique for silencing
targeted tumor suppressor genes, inducing a second mutation
within my organism of study (See Figure 4.2). This method utilizes
transgenes that encode specific RNAi sequences, which are
produced upon transcription of the transgene. Silencing occurs at
the post-transcriptional level, interfering with DNA regulation of
these specific genes (Hannon, 2002). Double stranded RNA
initiates this process upon recognition by the Dicer enzyme
(Hannon, 2002). As part of the RNase III ribonuclease family of
enzymes, Dicer possess two dicer molecules and five domains that
are able to process dsRNA, producing small interfering RNA’s
(Hannon, 2002). These siRNA’s are approximately 22 nucleotides
long due to an inactive site on the Dicer enzyme, which shifts the
targeted activity of this enzyme to Dicer family members (Hannon,
2002). Small interfering RNA’s are received by the RNA-induced
silencing complex, which serve as effector nucleases (Hannon,
2002). RISC effectively unwinds the siRNA’s through an ATPdependent process, thereby transforming from a zymogen into an
active
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complex (Hannon, 2002). When activated, the siRNA’s guide the
RISC complex to homologous substrates, with significant
complementation of sequences between the siRNA and mRNA
target (Hannon, 2002). Upon recognition, RISC-associated
nucleases cleave these mRNA substrates at specific sites thereby
inhibiting effective translation (Hannon, 2002). As such, these
steps characterize RNAi: “assembly of siRNA with the RNAinduced silencing complex, activation of the RISC, target
recognition and target cleavage” (Reynolds, et al, 2003).
By hindering this translational machinery, RNAi was
utilized within my Capstone Project to prevent protein synthesis of
specific tumor suppressor genes: dsh, dlg, ce, dsh, arm, shg, skpA,
ups7, vps25, scrib, cdc2, pten, cdc27, UASyki, cdc37, and tsc1. It
was expected that by silencing these genes that interfere with
tumor formation, the development of cancerous cells would be
stimulated. As such, this secondary mutation, in conjugation with
hyperactive Raf signaling, would theoretically lead to the
formation of malignant tumors in Drosophila melanogaster.
Identification of Ectopic-GFP Cells
FLP/FRT and UAS/Gal4 Systems
Both the FLP/FRT and UAS/Gal4 systems were vital in
targeting and identifying the presence of mutant cells. In order to
localize cancerous cells in the eye of Drosophila and tag these
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cells using Green Fluorescent Protein, the following stock was
used: ey-Flip; Act>IC>Gal4 UAS-GFP; UAS-dicer2.
The UAS/Gal4 system utilizes two components: a Gal4
driver and a Gal4 responsive UAS expression vector (Rorth, 1998).
When in the presence of Gal4, binding sites on the Upstream
Activator Sequence become occupied, thereby driving gene
expression (Rorth, 1998). Therefore, the presence of Gal4 is
necessary in order to activate the transcription of GFP (to mark the
cells) and Dicer 2 (an endonuclease that enhances the effectiveness
of RNAi) sequences (Duffy, 2002). As such, the absence of Gal4
expression effectively silences these UAS controlled reporter
genes (Duffy, 2002). In addition, in the progeny, the UAS-RNAi
transgene is also activated in the same cells, such that siRNAs are
generated and silence the targeted gene.
The expression of a reporter gene is able to be influenced
by cellular localization, timing, sensitivity, and protein and mRNA
stability (Duffy, 2002). Most noticeably, Gal4 expression is
affected by temperature, as minimal activity occurs below 16˚C
(Duffy, 2002). At 29˚C, Gal4 activity is maximal with few effects
on fertility and viability (Duffy, 2002).
Temporal and spatial expression of targeted genes is also
regulated by the FLP/FRT system, as it directly affects Gal4
expression. The flippase recombinant enzyme, FLP, allows for
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genetic recombination between the Flippase Recognition Target
sites (Duffy, 2002). As shown in Figure 4.3, the FRT sites
effectively flank the interruption cassette, which is responsible for
terminating transcription (Duffy, 2002). As the interruption
cassette is located between the promoter and Gal4 gene, its
presence effectively prohibits Gal4 expression (Duffy, 2002).
However, ey-Flip allows for the FLP enzyme to remove the
cassette, thereby promoting tissue-specific regulation within the
Drosophila eye tissue (Duffy, 2002). Since the ey-Flip is only
expressed in the developing eye-antennal tissue, the flippase
localizes GFP within the eye; therefore, metastasis is determined
based on the presence of ectopic GFP cells in secondary sites,
those other than the eye antennal epithelium. These systems
therefore effectively determine the loss of function phenotypes that
result from silencing tumor suppressor genes.
Experiments
RasACT and RafACT Preliminary Test
Before beginning my experimental project, it was crucial to
determine which Ras and Raf lines would be the most effective in
generating metastasis. Therefore, a preliminary test was performed,
in which each available Ras and Raf lines within the lab were
crossed to the ey-Flip; Act>IC>Gal4 UAS-GFP; UAS-dicer2 stock
(See Figure 4.4). In the first cross, the ey-Flip line was crossed to
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itself in order to induce double GFP expression. As such, this cross
showed the strongest GFP expression, so that all normally
expected areas of expression could be noted. Single GFP
expression was observed in the second cross, as this cross showed
comparable expression to that which was expected in the
experimental RNAi project. ey-Flip was also crossed to two Raf
lines: P{w[+mc]=UAS-hRaf1.gof}ra2. y[1]w[*], encoding an
activated form of human Raf, and w;FRT82B UAS-RafACT,
encoding the activated fly Raf. A total of three Ras lines, all
encoding activated fly Raf1, were also tested: w; FRT40A UASRasv12/CyO; UAS-Rasv12 on 3, and w; UAS-Rasv12/CyO;
FRT82B/TM6B.
As indicated in Figure 4.5, each of the Ras lines produced
greater overgrowth in the eye disc, in comparison to Raf. There
were also more secondary GFP expressing sites in Ras than in Raf,
displayed in Figure 4.6 as well. Although H-rafACT (gof) was the
only one of these lines to not show extra visualization systems, this
cross also produced the fewest progeny resulting in a smaller total
sample size in comparison to the other crosses. Ectopic GFP
typically appeared in the gut of the Rasv12 progeny, while RafACT
(FRT82B) secondary GFP expression was visible in the haltere
discs. Additionally, adult viability was greatest for 2X GFP and 1X
GFP expression, but somewhat diminished in the RafACT progeny
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and most severly affected in Rasv12 progeny. All Raf and Ras
crosses showed neuronal differentiation when stained with CY3.
The results of this screen indicated that the w; UASRasv12/CyO; FRT82B/TM6B line should be used as the
representative line for Ras in the experimental RNAi project. This
decision was due to the fact that Rasv12 (FRT82B) demonstrated
the greatest likelihood of producing secondary sites, as extreme
overproliferation was consistently observed during three separate
trials of testing.
According to this screen, the w; FRT82B UAS-RafACT line
would have been ideal to use for the experimental screen, as this
was the only Raf line that considerably proved to generate larger
overgrowths. However, in designing a screen to test for metastatic
cancer, it was more beneficial for overactive Raf to be carried on
the first chromosome, rather than the third. In addition, the use of
human Raf gene rather than fly Ras was appealing because any
observed genetic interaction would directly apply to the protein
found in human cancers. As such, the P{w[+mc]=UAShRaf1.gof}ra2. y[1]w[*] stock was bottlenecked in order to
increase the viability and health of these flies.
Generating RasACT and RafACT
Once it was determined which Ras and Raf lines would be
used for the experimental RNAi screen, it was necessary to create
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stable, healthy stocks containing these genotypes in order to test
for metastasis. The crossing schematic for Ras was designed,
incorporating the Ras genotype with both the TM3 and TM6B
markers, as shown in Figure 4.7, Rather than using the initial Ras
stock, it was necessary to create the new w; UAS-RASv12;
TM3/TM6B stock due to the presence of these markers. In
performing the experimental crosses, both TM3 and TM6B were
necessary in order to ensure that the final experimental flies were
carrying the correct genotype, by being scored for, and against,
both of these markers.
The first two crosses in the Ras schematic were performed
at the same time, as the female offspring of the first cross (w;
UAS-RASv12/CyOarmGFP; FRT82B) and male progeny of the
second (w; UAS-Rasv12/CyO; FRT82B/TM6B) were then crossed
together to generate the final desired genotype (w; UAS-Rasv12;
TM3/TM6B).
In order to produce this final stock, it was necessary that
the CyO marker was scored against, as the absence of curly wings
ensured the presence of homozygous Ras on the second
chromosome in the final line. Similarly, the presence of the TM3
and TM6B makers confirmed the absence of FRT82B in the
ultimate stock, which would have interfered with a necessary
mechanism in the experimental cross.
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As the line of Raf became more stable through the bottlenecking
process, the P{w[+mc]=UAS-hRaf1.gof}ra2. y[1]w[*] line was
also able to be used in order to generate the appropriate stock for
the experimental screen (Figure 4.8). First, this stock was crossed
against a line carrying both the TM3 and TIM6B markers; two
different males were collected from this cross, with each carrying
one of these markers and the overactive Raf genotype. Males
carrying each of these genotypes were crossed back to the original
stock in order to produce females that were homozygous for
hyperactive Raf, whereas this was not genetically possible in the
first cross. These progeny were crossed so that a stock completely
homozygous for Raf could be produced, also carrying both the
TM3 and TM6B phenotypic markers.
However, the Raf line also demonstrated an extreme
weakness in the presence of both balancers. In order to ensure the
viability of the stock, a bottle was made that contained flies that
were either TM3 or wild type over TM6B. It was necessary to
retain the TM6B marker, as this marker allows for larval scoring,
which was necessary in the experimental cross. This bottle was
also bottlenecked and expanded; the UAS-RafACT; III/TM6B
genotype became more dominant over time due to an increased
viability in these flies, in comparison to those flies carrying both
markers.
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Although the intention was to use both of the newly
generated stocks in the experimental screens, the w; UAS-Rasv12;
TM3/TM6B stock could not be utilized. Despite using robust
crosses, very few flies carrying this genotype were produced, with
even a fewer amount of healthy flies. Although similar results
occurred in creating the Raf stock, a greater among of healthy,
viable flies were produced in comparison to Ras. As such, the Raf
line was able to be easily bottlenecked for the final experiment,
while Ras was not. These flies also exhibited an extreme
sensitivity to temperature, as viability drastically decreased with an
increase in the environmental temperature. After discovering this
fact, these flies were maintained at 18˚C throughout the remainder
of the bottlenecking process. However, even in an optimal
temperature environment, these flies were too weak to survive, let
alone be able to be used for the experimental screen.
Preliminary Screen
The main purpose of the first preliminary screen was to test
the effectiveness of the newly created Raf stock in generating
metastasis. Although the final Ras stock was unable to be used, the
experimental screen was still designed and implemented using
UAS-RafACT; III/TM6B as shown in Figure 4.9. These flies were
mated to males that carried UAS-RNAi transgenes that when
activated would silence tumor suppressor loci by RNAi. Male
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offspring were then mated to females of the ey-Flip; Act>IC>Gal4
UAS-GFP; UAS-dicer2 genotype. While the first cross combined
the two mutations-inducing transgenes within the fly, hyperactive
Raf and the tumor suppressor gene RNAi, the second ensured the
localization and visualization of cancerous cells using Green
Fluorescent Protein.
In the final cross, four types of progeny were produced,
with only one containing the desired genotype, ey-Flip/UASRafACT/Actin>IC>Gal4 UAS-GFP; UAS-dicer2/UAS-RNAi
(Figure 4.10). The other three possible genotypic offspring served
as controls with either the tumor suppressor gene being present or
hyperactive Raf being absent, or with one type of progeny carrying
neither. Only the ey-Flip/UAS-RafACT; Act>IC>Gal4 UAS-GFP;
UAS-dicer2/TM6B progeny were scored, as these determined the
phenotype of hyperactive Raf.
A subset of RNAi genes were selected for this screen as
well, based on their suspected involvement in metastasis
development and their proven effectiveness in down regulating the
targeted gene based on mutant effects induced in the eye: vsp25,
ce, dsh, arm, shg, skpA, ups7, and dlg (Figure 4.11). Larval
analysis for ups7 and dlg showed the presence of ectopic cells at
both the anterior and posterior, at a respective ratio of 1:7 and 4:11.
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As shown in Figure 4.12. GFP positive cells were observed in the
larval midsection for two dlg experimental samples. Two other dlg
samples (not shown) expressed GFP in the anterior of larvae, with
one of the samples also showing ectopic expression in the midsection as well. Only one (out of seven) Ups7 larvae was
metastatic, expressing green fluorescent protein at the anterior. All
controls expressed green fluorescent protein within the eye
antennal epithelium and part of the brain lobes, as expected.
Pilot Screen
After it was confirmed that silenced tumor suppressor
genes, in combination with RafACT, were able to induce metastasis,
a larger pilot screen was performed. Since dlg and ups7 generated
ectopic GFP cells in the preliminary screen, these genes were retested in the secondary screen. Eight other genes were selected
based on previous research performed, indicating the involvement
of these genes in the regulatory processes relating to metastasis:
scrib, pten, uasyki, dsh, cdc27, cdc2, cdc37, and tsc1 (Figure
4.13). Specifically, extensive research has been done on the
knockdown effects of scrib, dlg, and dsh in conjugation with
hyperactive Ras, in causing metastatic behavior. Therefore, it was
expected that the silencing of these genes would induce the
presence of ectopic cells when combined with overactive Raf.
These genes did in fact advance the formation of malignant
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cancers; pten and UAS-yki, which caused for the overexpression
instead of knockdown of the Yki protein, also showed similar
results.
As seen in Figures 4.14/4.15/4.16, the suppression of scrib
and dlg produced the greatest metastatic rate; suppression of pten
or dsh and the overexpression of yki were only able to trigger
cancer less robustly, at rates of 5.6%, 5.6%, and 7.1% respectively.
Both tsc1 and cdc27 had less than a 4% chance of showing
metastasis. Within the controls tested, ectopic cells were present in
one larvae, generating a 0.5% metastatic rate for the total sample
size (Figure 4.17).
In order to determine the relationship between larval
development and metastatic rate, experimental samples were rescored as pupae (Figures 4.18 and 4.19). While each of these
samples contained the desired genotype, none of these larvae
contained ectopic GFP cells as larvae. However, these samples
exhibited a 7.1% chance of forming malignant tumors at a later
stage in development. These samples also consistently exhibited
tissue shrinkage from the pupal encasing, interfering with eclosion
and thereby causing death. As such, the development of cancer in
Drosophila mirrors the progression of the disease within humans,
strengthening in development over time.
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However, some larvae also exhibited no GFP expression;
this was most likely due to interference by the RNAi mechanism;
RNAi expressing cells possibly may have died thereby causing an
absence of GFP expression. It should also be noted that control
samples containing RafACT, which did not previously contain
ectopic GFP cells, later indicated metastasis with a 24% metastatic
rate. As demonstrated in the Ras vs. Raf screen, hyperactive
signaling sometimes resulted in ectopic GFP expression. While
this result was not expected, its occurrence is most likely
correlated with inefficiencies in the FLP/FRT and UAS/Gal4
systems. An inefficient flippase enzyme would have been
unsuccessful in its role to localize GFP expression to the epithelial
tissue of larvae.
Larvae of the original ey-Flip; Act>IC> Gal4 UAS-GFP;
UAS-dicer2 were analyzed under the fluorescence microscope in
order to test this theory. Some larvae exhibited GFP expression
throughout all tissues, thereby substantiating the imperfections
within the ey-Flip stock.
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5. FUTURE DIRECTION
Important Cellular Processes
As noted by the experimental results, suppressed scribble
(scrib) and discs large (dlg) produced the most significant rate of
metastasis, in concert with hyperactive Raf. Extensive research has
proven both of these genes to be involved in the processes of
cellular polarity; mutations in both scrib and dlg have been known
to cause overgrowth phenotypes and defects in epithelial
monolayer formation (Pagliarini, 2003). It has been suggested that
the involvement of these genes in “the abrogation of inter-cellular
junctions or the mislocalization of plasma membrane-targeted
signaling molecules” prevents the formation of NONinvasive
tumors (Pagliarini, 2003). Likewise, the conserved scaffolding
protein that is encoded by scrib and dlg is also necessary in
maintaining cell polarity (Halder and Mills, 2011). Therefore the
existence of these genes within the Drosophila genotype is
necessary in order to ensure proper apical-basal cell polarity and
consequently normal, healthy epithelial cells (Halder and Mills,
2011).
Future Connections
By identifying the cellular processes that are related to
cancer, like cell polarity and epithelial monolayer formation, more
advances can be made in the field of oncology. By understanding
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such connections, the nature of cancer can be further questioned
through analyzing the initiating effects of various molecular and
cellular processes in cancer development. For instance, it is quite
possible that the characteristics of this disease could vary based on
whether suppression occurs in cell polarity or vesicular trafficking
proteins. By identifying the biological role of specific proteins,
questions like these can be addressed and the inherent qualities of
cancer can be further understood.
Development of Screen
Based on the pilot screen, a larger-scale screen could be
generated to further test the metastatic effects of UAS-RafACT;
III/TM6B. Tumor suppression genes that consistently lead to green
offsites could also be analyzed using different hyperactive
signaling pathways, like with Notch or EGFR. By comparatively
studying the interaction of these pathways with the mutated genes,
it can be determined if all tumor cells are inherently the same or
not in terms of which second site hits best promote metastasis.
As such, the newly generated Raf stock, from my Capstone,
could be useful in determining the roles and regulatory processes
of specific genes, as well as helping researchers to further
understand malignant growth.

67

6. REFERENCES
Basler, K, Toggwiler, J, Willecke, M. (2011). Loss of PI3K Blocks
Cell-Cycle Progression in Drosophila Tumor Model.
Oncogene (e-pub ahead of print; doi:10.1038/onc.2011.125).
Benvenuti S, Sartore-Bianchi A, Di Nicolantonio F, et al. (2007).
Oncogenic Activation of the RAS/RAF Signaling Pathway
Impairs the Response of Metastatic Colorectal Cancers to
Anti-Epidermal Growth Factor Receptor Antibody
Therapies. Cancer Research 67: 2643-2648.
Childress, J, Behringer, R, and Halder, G. 2005. Learning to Fly:
Phenotypic Markers in Drosophila. Poster. Genesis.
“Cancer Facts & Figures 2012.” American Cancer Society. 2012.
23 Feb. 2012.
<http://www.cancer.org/Research/CancerFactsFigures/Cancer
FactsFigures/cancer-facts-figures-2012 >.
Duffy, J. 2002. GAL4 System in Drosophila: A Fly Geneticist's
Swiss Army Knife. Genesis 34: 1-15.
Greenspan, Ralph J. Fly Pushing: The Theory and Practice of
Drosophila Genetics. 2nd ed. Cold Spring Harbor: Cold
Spring Harbor Laboratory Press, 2004.
Halder, G, Mills, GB. (2011). Drosophila in Cancer Research: to
Boldly Go Where No One Has Gone Before. Oncogene (e-pub
ahead of print; doi:10.1038/onc.2011.128).

68

Hanahan, D, Weinberg, R. (2000). The Hallmarks of Cancer. Cell
100: 57-70.
Hannon, G. 2002. RNA interference. Nature 418: 244-251.
Janda, E, Lehmann, K, Killisch, I, Jechlinger, M, Herzig, M,
Downward, J, Beug, H, Grünert, S. (2002). Ras and
TGF[beta] cooperatively regulate epithelial cell plasticity
and metastasis: dissection of Ras signaling pathways. Cell
152: 299-313.
Knudson, Alred G. Two genetic hits (more or less) to cancer. 2001.
Review. Nature 1: 157-162.
“Knudson’s ‘Two-Hit’ Theory of Cancer Causation.” Fox Chase
Cancer Center.
<http://www.fccc.edu/research/areas/advisors/knudson/two
Hit.html >.
Lengauer, C, Kinzler, K.W.and Vogelstein, B. (1998). Genetic
Instabilities in Human Cancers. Nature 396: 643–649.
Liotta LA, Steeg PS, Stetler-Stevenson WG. (1991). Cancer
Metastasis and Angiogenesis: An Imbalance of Positive
and Negative Regulation. Cell 64: 327-336.
Pagliarini, R, et al. (2003). A Genetic Screen in Drosophila for
Metastatic Behavior. Science 302: 1227-1231.

69

Powell, Jeffery R. 1997. Progress and Prospects in Evolutionary
Biology: The Drosophila Model. New York: Oxford Univ.
Press. 562 pp.
Reuter CW, Morgan M, Bergmann L. (2000). Targeting the RAS
Signaling Pathway: a Rational, Mechanism-based
Treatment in Hematological Malignancies. Blood 96: 16551669.
Reynolds, A, Leake, D, Boese, Q, Scaringe, S, Marshall, W, and
Khvorova A. 2003. Rational siRNA Design for RNA
Interference. Nature Biotechnology 22: 326-330.
Rorth, P. 1998. Gal4 in the Drosophila female germline.
Mechanisms of Development 78: 113-118.
The Arrogant Scientist. “The Differences Between the Sexes.”
Blog. 6 Mar. 2009. Word Press. 26 Mar. 2012.
<http://arrogantscientist.wordpress.com/2009/03/06/thedifferences-between-the-sexes/>.
Twyman, Richard. “Model Organisms: The Fruit Fly.” The Human
Genome. 29 Aug. 2002.
<http://genome.wellcome.ac.uk/doc_WTD020807.html>.
“Understanding Cancer Series”. National Cancer Institute at the
National Institutes of Health.
<http://www.cancer.gov/cancertopics/understandingcancer/
cancer/page9>.

70

7. SUMMARY
Cancer is an extremely complex disease, as tumorigenesis
requires mutations in tumor suppressor and oncogenes (Basler,
Toggwiler, and Willecke). However, over the years, oncogenic
research has proved there to be six fundamental traits of cancer: a
“self-sufficiency in growth signals, insensitivity to growthinhibitory (antigrowth) signals, evasion of programmed cell death
(apoptosis), limitless replicative potential, sustained angiogenesis,
and tissue evasion and metastasis” (Hanahan and Weinberg).
While each of these identified qualities contribute to the lethality
of the disease, my Capstone project specifically focuses on the
topic of tissue evasion and cancer metastasis.
Both benign and malignant tumors possess the first five
fundamental traits of cancer, only differing in their ability to evade
tissues and thereby infect new areas of the body. Cancer is
described as being benign when the disease is localized to a
specific area within an organism, demonstrating no outward
growth from the disease’s initial area of formation. In contrast,
malignant cancer is extremely dangerous as it visibly moves to
new locations within the body, creating metastatic sites.
Metastatic sites form when an area that was previously
unoccupied by cancerous cells, exhibits the presence of new,
cancerous cells (Hanahan and Weinberg). By migrating from the
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original location of the disease to a non-adjacent area within the
body, cancerous cells cause for new sites to become infected by the
disease (Hanahan and Weinberg). There are multiple mechanisms
that enable such movement of cancerous cells, like uncontrolled
mitosis or angiogenesis (Hanahan and Weinberg). Angiogenesis
enables cancer cells to utilize the blood stream or lymphatics in
order to metastasize, while mitosis refers to the uncontrollable
division of cancerous cells (Hanahan and Weinberg). Both of these
qualities are dependent upon the other fundamental traits of cancer.
As proposed by Dr. Knudson, there is also a simplified
model of the development of cancer termed the “two-hit” theory
(Knudson’s ‘Two-Hit’ Theory of Cancer Causation). Knudson
suggests that the causation of cancer is heavily based on multiple
chromosomal mutations (Knudson’s ‘Two-Hit’ Theory of Cancer
Causation). While the first “hit” makes an organism more
susceptible to developing the disease, the second “hit” is most
likely to cause for cancer (Knudson’s ‘Two-Hit’ Theory of Cancer
Causation). This theory is reflected in my Capstone Project, as I
utilized the effects of two separate mutations, in both tumor
suppressor and oncogenes, as a leading cause to metastasis in
Drosophila melanogaster.
The first mutation in my experiment was in a specific
signaling pathway, since overactive signal transduction pathways
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have also been known to contribute to the formation of cancer.
Within this pathway, a signal or ligand is received by a growth
factor receptor, initiating an appropriate cellular response within
the cell. Phosphorylation allows for the activation of proteins
through the addition of a phosphate molecule, regulating the
desired activation level within a pathway. As such, the behavior of
overactive signaling pathways is as if the proteins within the
transduction pathway are continually phosphorylated, or activated.
Manipulation of signaling pathways can also mimic the effects of
the constant presence of a ligand or signal, which would also cause
for the pathway to be overactive.
The pathway that I specifically manipulated was an MAPK
signaling pathway called the RAS-RAF pathway (Research
BRAF). In this pathway there are two types of protein kinases, Ras
and Raf, which are responsible for relaying the extracellular signal
within the cell (Research BRAF). Mutations to the RAS-RAF
pathway can cause changes in cell differentiation, proliferation,
and growth – three processes that this pathway is responsible in
controlling for normal cell function (Research BRAF). In order to
determine the most effective hyperactive Ras and Raf lines to use,
each available stock was analyzed to distinguish which caused the
greatest proliferation within larval eye tissues. Originally, two
stable stocks for hyperactive Ras and Raf were created; however,
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due to a substantial weakness in the Ras line, it was eliminated
from the experimental project. Therefore, in my project, I used a
Raf mutant protein in order to create a hyperactive GTPase
signaling pathway within a specific line of flies.
These tester flies were mated to a separate line of flies that
carried a transgene with the ability to silence targeted genes, using
RNA interference. By decreasing the activity of specific genes,
RNA interference enabled me to create a second mutation in my
project, causing the progeny flies to be more susceptible to
developing cancer.
The offspring carried a genome that had an overactive as
well as a “knocked-out” gene and consequently were analyzed for
the occurrence of metastasis. Analysis was possible due to the
UAS/Gal-4 and FLP/FRT systems and by the presence of the
protein marker, green fluorescent protein, which localized
expression of GFP in the eye tissue of normal, or wild type, larvae.
As such, the occurrence of metastasis was verified when GFP
positive cells were detected in locations other than the developing
head epithelium.
Originally larvae were analyzed in vitro, however later the
procedure changed to an in vivo approach due to a better
visualization of metastasis within living, intact larvae. A
preliminary screen was performed in order to test the effectiveness
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of the final overactive Raf stock, by crossing this line of flies to a
subset of genes: vps25, ce, dsh, arm, shg, skpA, ups7, and dlg.
Ectopic behavior was observed in dlg and ups7; once it was
confirmed that the newly constructed Raf line was able to induce
metastasis, in conjugation with the suppression of specific genes, a
pilot screen was designed. In this final screen a variety of genes
were also tested including scrib, dlg, cdc2, pten, ups7, cdc27,
UASyki, cdc37, tsc1, and dsh. Ectopic expression of GFP and the
occurrence neoplastic growth was most significant in scrib and dlg.
In the scientific community, extensive research has been
performed on both scrib and dlg, using a mutant Ras protein. This
research has indicated the biological processes of both scribble and
discs large to be involved in cell polarity (Pagliarini, 2003).
Mutations in these genes also caused for defects in epithelial
monolayer formation (Pagliarini, 2003). As such both cellular
polarity and epithelial monolayer formation are critical in
preventing the metastasis of cancer (Pagliarini, 2003).
In performing a novel screen, it was discovered that scrib and dlg,
in combination with RAFACT, led to metastatic cancer. This
indicates that an overactive Raf pathway, in conjugation with these
silenced cell polarity genes, is also able to cause defects in the
normal functioning of cells. As such, both of these mutations are
necessary in order to induce metastatic behavior.
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